The polymyxin resistance testing market size is projected to be worth US$ 122.0 million in 2023. The market is likely to surpass US$ 222.5 million by 2033 at a CAGR of 6.2% during the forecast period. The industry that develops, produces, and distributes tests and assays intended to identify and evaluate resistance to polymyxin antibiotics is referred to as the Polymyxin Resistance Testing Market. A class of antibiotics known as polymyxins is used to treat severe infections brought on by bacteria that are multidrug resistant, particularly Gram-negative bacteria.
Bacteria that have acquired genetic mutations or resistance genes that make them less vulnerable to or entirely resistant to the effects of polymyxin antibiotics develop polymyxin resistance. Testing for polymyxin resistance is performed to find these resistant bacteria and establish the best course of therapy.
Other Drivers Propelling the Demand for Polymyxin Resistance Testing include:
Challenges for Companies /Manufacturers in the Polymyxin Resistance Testing Market:
Opportunities in the Polymyxin Resistance Testing Industry:
Latest Trends in the Polymyxin Resistance Testing Market:
| Attributes | Details |
|---|---|
| Polymyxin Resistance Testing Market Size (2023) | US$ 122.0 million |
| Polymyxin Resistance Testing Market Projected Size (2033) | US$ 222.5 million |
| Value CAGR (2023 to 2033) | 6.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2017 to 2022, the global polymyxin resistance testing market experienced a CAGR of 6.0%, reaching a market size of US$ 122.0 million in 2023.
From 2017 to 2022, As multidrug-resistant Gram-negative bacteria are becoming more common, polymyxin resistance has grown to be a serious issue in the field of antimicrobial resistance. The market's historical outlook shows that this issue has been acknowledged, and that there is a consequent need for efficient testing procedures to detect and control polymyxin resistance.
Future Forecast for Polymyxin Resistance Testing Industry:
Looking ahead, the global polymyxin resistance testing industry is expected to rise at a CAGR of 6.2% from 2023 to 2033 reaching valuation of US$ 222.5 million by the end of 2033. The rise in polymyxin-resistant bacterial infections, such as carbapenem-resistant Enterobacteriaceae (CRE) and multidrug-resistant Gram-negative bacteria, is expected to drive the demand for polymyxin resistance testing. As antimicrobial resistance becomes a global health concern, the need for accurate and timely testing to guide
| Country | The United States |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 56.1 million |
| CAGR % 2023 to End of Forecast (2033) | 6.2% |
The polymyxin resistance testing industry in the United States is expected to reach a market size of US$ 56.1 million by 2033, expanding at a CAGR of 6.2%. In order to reduce the risk of healthcare-associated infections (HAIs), infection control techniques have received a lot of attention in healthcare settings, including hospitals and long-term care facilities. Healthcare practitioners can implement effective infection control measures by using polymyxin resistance tests to identify patients who have been colonized or infected with polymyxin-resistant bacteria. Testing for polymyxin resistance is more popular due to rising infection control knowledge and emphasis.
| Country | The United Kingdom |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 7.4 million |
| CAGR % 2023 to End of Forecast (2033) | 4.8% |
The polymyxin resistance testing industry in the United Kingdom is expected to reach a market value of US$ 7.4 million, expanding at a CAGR of 4.8% during the forecast period. The UK government has implemented various initiatives and policies to address the challenge of antibiotic resistance. These initiatives include the UK Five-Year Antimicrobial Resistance Strategy and the Antimicrobial Resistance (AMR) Action Plan. The government and regulatory bodies provide support and guidance for the development and implementation of accurate and reliable resistance testing methods, including polymyxin resistance testing. The supportive regulatory environment encourages market growth.
| Country | China |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 19.0 million |
| CAGR % 2023 to End of Forecast (2033) | 7.5% |
The polymyxin resistance testing industry in China is anticipated to reach a market size of US$ 19.0 million, moving at a CAGR of 7.5% during the forecast period. China has been increasing its healthcare expenditure and focusing on the development of healthcare infrastructure. This includes the expansion and improvement of diagnostic facilities and laboratory capabilities. The investment in healthcare infrastructure supports the adoption of advanced testing methods, including polymyxin resistance testing, and contributes to market growth.
| Country | Japan |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 13.3 million |
| CAGR % 2023 to End of Forecast (2033) | 7.1% |
The polymyxin resistance testing industry in Japan is estimated to reach a market size of US$ 13.3 million by 2033, thriving at a CAGR of 7.1%. Japan has a well-developed healthcare infrastructure, including sophisticated diagnostic facilities and laboratory capabilities. The availability of advanced technologies and equipment facilitates the adoption of cutting-edge diagnostic methods, including polymyxin resistance testing. The advanced healthcare infrastructure supports the growth of the market by enabling accurate and efficient testing.
| Country | South Korea |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 5.6 million |
| CAGR % 2023 to End of Forecast (2033) | 6.6% |
The polymyxin resistance testing industry in South Korea is expected to reach a market size of US$ 5.6 million, expanding at a CAGR of 6.6% during the forecast period. Research and development activities in the field of polymyxin resistance testing are promoted in South Korea through cooperative efforts between research institutions, healthcare organizations, and industry participants. Joint research projects seek to improve testing procedures, broaden the spectrum of observable resistance mechanisms, and increase data reporting and interpretation. The Polymyxin Resistance Testing Market in South Korea is expanding due to cooperative research and development initiatives.
Principal Consultant
The testing systems is expected to dominate the polymyxin resistance testing industry with a CAGR of 6.4% from 2023 to 2033. Testing systems are designed to detect the presence of specific resistance mechanisms or genes that confer resistance to polymyxin antibiotics. These systems employ various techniques, such as polymerase chain reaction (PCR), DNA sequencing, and phenotypic testing, to identify resistance in bacterial strains. Accurate and reliable detection of polymyxin resistance is essential for guiding appropriate treatment decisions and preventing the spread of resistant strains.
The Broth Microdilution (BMD) segments are expected to grow at significant rate due to its greater adoption as compared other testing methods within the polymyxin resistance testing industry with a CAGR of 7.0% from 2023 to 2033. Broth Microdilution (BMD) is a widely accepted and standardized method for testing bacterial susceptibility to antimicrobial agents, including polymyxins. It involves diluting antimicrobial agents in a liquid growth medium, inoculating bacterial strains, and measuring the minimum inhibitory concentration (MIC) of the drug required to inhibit bacterial growth. The standardized nature of BMD ensures consistent and reproducible results, making it a valuable tool for researchers, clinicians, and regulatory authorities.
The academic & research institutions segment is expected to dominate the polymyxin resistance testing industry with a CAGR of 7.0% from 2023 to 2033. Academic and research institutions play a vital role in the development and validation of testing methods for polymyxin resistance. They conduct extensive research to identify new resistance mechanisms, understand the genetic basis of resistance, and develop innovative testing approaches. This research contributes to the advancement of testing methods, enabling more accurate and reliable detection of polymyxin resistance.
The market for polymyxin resistance testing is highly competitive, with numerous businesses vying for supremacy. Important players must use cunning tactics in such a situation to stay ahead of the opposition.
Key Strategies Used by the Participants
To produce innovative goods that increase efficacy, dependability, and cost-effectiveness, businesses make significant investments in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.
Key industry leaders frequently develop strategic partnerships and collaborations with other companies in order to harness their strengths and increase their market reach. Companies might also gain access to new technology and markets through such agreements.
The polymyxin resistance testing sector is expanding rapidly in emerging regions such as China and India. Key firms are enhancing their distribution networks and developing local manufacturing facilities to increase their presence in these areas.
Mergers and acquisitions are frequently used by key players in the polymyxin resistance testing business to consolidate their market position, extend their product range, and gain access to new markets.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Polymyxin Resistance Testing Market:
In 2023, the market is likely to generate US$ 122 million revenue.
The market is poised to witness 6.2% CAGR through 2033.
The testing systems segment is poised to expand at 6.4% CAGR up till 2033.
The United States polymyxin resistance testing market could witness 6.2% CAGR until 2033.
Polymyxin resistance testing in China is poised to record a 7.5% CAGR through 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption / Usage Analysis
4.2. Product Features/ USPs
4.3. Technological Roadmap
4.4. Recent Product Approvals/Launches
4.5. Regulatory Landscape
4.6. PESTEL Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Increasing Cases of Bacterial Infections
5.2.3. Favourable Government Regulations
5.2.4. Technological Advancement in the Devices
5.2.5. Increasing Prevalence of Antimicrobial Resistance
5.2.6. Key Strategies by Manufacturers
5.2.7. Frequency of Product Approvals
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033
6.1. Historical Volume (in Units) Analysis, 2017 to 2022
6.2. Current and Future Volume (in Units) Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market - Pricing Analysis
7.1. Regional Pricing Analysis By Product
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark
7.4. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2017 to 2022
9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033
9.3.1. Testing Systems
9.3.2. Test Kits & Identification Panels
9.3.3. Reagents & Consumables
9.4. Market Attractiveness Analysis By Product
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Testing Method
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Testing Method, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Testing Method, 2023 to 2033
10.3.1. Broth Microdilution (BMD)
10.3.2. Disk Diffusion
10.3.3. Etest (Broth Microdilution + Disk Diffusion)
10.3.4. Polymerase Chain Reaction (PCR)
10.4. Market Attractiveness Analysis By Testing Method
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
11.3.1. Clinical Laboratories
11.3.2. Academic & Research Institutions
11.3.3. Pharmaceutical/Biotech Companies
11.3.4. Food & Environmental Testing Laboratories
11.3.5. Veterinary Diagnostic Laboratories
11.4. Market Attractiveness Analysis By End User
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. USA
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By Testing Method
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Testing Method
13.4.4. By End User
13.5. Country Level Analysis & Forecast
13.5.1. USA Market Analysis
13.5.1.1. .Introduction
13.5.1.2. Market Analysis and Forecast by Market Taxonomy
13.5.1.2.1. By Product
13.5.1.2.2. By Testing Method
13.5.1.2.3. By End User
13.5.2. Canada Market Analysis
13.5.2.1. Introduction
13.5.2.2. Market Analysis and Forecast by Market Taxonomy
13.5.2.2.1. By Product
13.5.2.2.2. By Testing Method
13.5.2.2.3. By End User
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By Testing Method
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Testing Method
14.4.4. By End User
14.5. Country Level Analysis & Forecast
14.5.1. Brazil Market Analysis
14.5.1.1. .Introduction
14.5.1.2. Market Analysis and Forecast by Market Taxonomy
14.5.1.2.1. By Product
14.5.1.2.2. By Testing Method
14.5.1.2.3. By End User
14.5.2. Mexico Market Analysis
14.5.2.1. Introduction
14.5.2.2. Market Analysis and Forecast by Market Taxonomy
14.5.2.2.1. By Product
14.5.2.2.2. By Testing Method
14.5.2.2.3. By End User
14.5.3. Argentina Market Analysis
14.5.3.1. Introduction
14.5.3.2. Market Analysis and Forecast by Market Taxonomy
14.5.3.2.1. By Product
14.5.3.2.2. By Testing Method
14.5.3.2.3. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. France
15.3.1.3. Italy
15.3.1.4. UK
15.3.1.5. Spain
15.3.1.6. Russia
15.3.1.7. BENELUX
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By Testing Method
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Testing Method
15.4.4. By End User
15.5. Country Level Analysis & Forecast
15.5.1. Germany Market Analysis
15.5.1.1. .Introduction
15.5.1.2. Market Analysis and Forecast by Market Taxonomy
15.5.1.2.1. By Product
15.5.1.2.2. By Testing Method
15.5.1.2.3. By End User
15.5.2. France Market Analysis
15.5.2.1. Introduction
15.5.2.2. Market Analysis and Forecast by Market Taxonomy
15.5.2.2.1. By Product
15.5.2.2.2. By Testing Method
15.5.2.2.3. By End User
15.5.3. Italy Market Analysis
15.5.3.1. Introduction
15.5.3.2. Market Analysis and Forecast by Market Taxonomy
15.5.3.2.1. By Product
15.5.3.2.2. By Testing Method
15.5.3.2.3. By End User
15.5.4. UK Market Analysis
15.5.4.1. .Introduction
15.5.4.2. Market Analysis and Forecast by Market Taxonomy
15.5.4.2.1. By Product
15.5.4.2.2. By Testing Method
15.5.4.2.3. By End User
15.5.5. Spain Market Analysis
15.5.5.1. .Introduction
15.5.5.2. Market Analysis and Forecast by Market Taxonomy
15.5.5.2.1. By Product
15.5.5.2.2. By Testing Method
15.5.5.2.3. By End User
15.5.6. Russia Market Analysis
15.5.6.1. .Introduction
15.5.6.2. Market Analysis and Forecast by Market Taxonomy
15.5.6.2.1. By Product
15.5.6.2.2. By Testing Method
15.5.6.2.3. By End User
15.5.7. BENELUX Market Analysis
15.5.7.1. .Introduction
15.5.7.2. Market Analysis and Forecast by Market Taxonomy
15.5.7.2.1. By Product
15.5.7.2.2. By Testing Method
15.5.7.2.3. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By Testing Method
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Testing Method
16.4.4. By End User
16.5. Country Level Analysis & Forecast
16.5.1. India Market Analysis
16.5.1.1. .Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Product
16.5.1.2.2. By Testing Method
16.5.1.2.3. By End User
16.5.2. Thailand Market Analysis
16.5.2.1. .Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Product
16.5.2.2.2. By Testing Method
16.5.2.2.3. By End User
16.5.3. Indonesia Market Analysis
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Product
16.5.3.2.2. By Testing Method
16.5.3.2.3. By End User
16.5.4. Malaysia Market Analysis
16.5.4.1. Introduction
16.5.4.2. Market Analysis and Forecast by Market Taxonomy
16.5.4.2.1. By Product
16.5.4.2.2. By Testing Method
16.5.4.2.3. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By Testing Method
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Testing Method
17.4.4. By End User
17.5. Country Level Analysis & Forecast
17.5.1. China Market Analysis
17.5.1.1. .Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Product
17.5.1.2.2. By Testing Method
17.5.1.2.3. By End User
17.5.2. Japan Market Analysis
17.5.2.1. Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Product
17.5.2.2.2. By Testing Method
17.5.2.2.3. By End User
17.5.3. South Korea Market Analysis
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Product
17.5.3.2.2. By Testing Method
17.5.3.2.3. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By Testing Method
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Testing Method
18.4.4. By End User
18.5. Country Level Analysis & Forecast
18.5.1. Australia Market Analysis
18.5.1.1. .Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Product
18.5.1.2.2. By Testing Method
18.5.1.2.3. By End User
18.5.2. New Zealand Market Analysis
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Product
18.5.2.2.2. By Testing Method
18.5.2.2.3. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Türkiye
19.3.1.3. Northern Africa
19.3.1.4. South Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By Testing Method
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Testing Method
19.4.4. By End User
19.5. Country Level Analysis & Forecast
19.5.1. GCC Countries Market Analysis
19.5.1.1. .Introduction
19.5.1.2. Market Analysis and Forecast by Market Taxonomy
19.5.1.2.1. By Product
19.5.1.2.2. By Testing Method
19.5.1.2.3. By End User
19.5.2. Türkiye Market Analysis
19.5.2.1. Introduction
19.5.2.2. Market Analysis and Forecast by Market Taxonomy
19.5.2.2.1. By Product
19.5.2.2.2. By Testing Method
19.5.2.2.3. By End User
19.5.3. Northern Africa Market Analysis
19.5.3.1. Introduction
19.5.3.2. Market Analysis and Forecast by Market Taxonomy
19.5.3.2.1. By Product
19.5.3.2.2. By Testing Method
19.5.3.2.3. By End User
19.5.4. South Africa Market Analysis
19.5.4.1. Introduction
19.5.4.2. Market Analysis and Forecast by Market Taxonomy
19.5.4.2.1. By Product
19.5.4.2.2. By Testing Method
19.5.4.2.3. By End User
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
21. Competition Analysis
21.1. Competition Dashboard
21.2. Branding and Promotional Strategies, By Key Players
21.3. Key Development Analysis
21.4. Competition Deep Dive
21.4.1. Thermofisher Scientific
21.4.1.1. Overview
21.4.1.2. Product Portfolio
21.4.1.3. Key Financials
21.4.1.4. Sales Footprint
21.4.1.5. SWOT Analysis
21.4.1.6. Strategy Overview
21.4.1.6.1. Marketing Strategy
21.4.1.6.2. Product Strategy
21.4.1.6.3. Channel Strategy
21.4.2. Mast Group
21.4.2.1. Overview
21.4.2.2. Product Portfolio
21.4.2.3. Key Financials
21.4.2.4. Sales Footprint
21.4.2.5. SWOT Analysis
21.4.2.6. Strategy Overview
21.4.2.6.1. Marketing Strategy
21.4.2.6.2. Product Strategy
21.4.2.6.3. Channel Strategy
21.4.3. Liofilchem
21.4.3.1. Overview
21.4.3.2. Product Portfolio
21.4.3.3. Key Financials
21.4.3.4. Sales Footprint
21.4.3.5. SWOT Analysis
21.4.3.6. Strategy Overview
21.4.3.6.1. Marketing Strategy
21.4.3.6.2. Product Strategy
21.4.3.6.3. Channel Strategy
21.4.4. Rosco Diagnostica A/S
21.4.4.1. Overview
21.4.4.2. Product Portfolio
21.4.4.3. Key Financials
21.4.4.4. Sales Footprint
21.4.4.5. SWOT Analysis
21.4.4.6. Strategy Overview
21.4.4.6.1. Marketing Strategy
21.4.4.6.2. Product Strategy
21.4.4.6.3. Channel Strategy
21.4.5. bioMérieux SA
21.4.5.1. Overview
21.4.5.2. Product Portfolio
21.4.5.3. Key Financials
21.4.5.4. Sales Footprint
21.4.5.5. SWOT Analysis
21.4.5.6. Strategy Overview
21.4.5.6.1. Marketing Strategy
21.4.5.6.2. Product Strategy
21.4.5.6.3. Channel Strategy
21.4.6. Meridian
21.4.6.1. Overview
21.4.6.2. Product Portfolio
21.4.6.3. Key Financials
21.4.6.4. Sales Footprint
21.4.6.5. SWOT Analysis
21.4.6.6. Strategy Overview
21.4.6.6.1. Marketing Strategy
21.4.6.6.2. Product Strategy
21.4.6.6.3. Channel Strategy
21.4.7. Beckman Coulter
21.4.7.1. Overview
21.4.7.2. Product Portfolio
21.4.7.3. Key Financials
21.4.7.4. Sales Footprint
21.4.7.5. SWOT Analysis
21.4.7.6. Strategy Overview
21.4.7.6.1. Marketing Strategy
21.4.7.6.2. Product Strategy
21.4.7.6.3. Channel Strategy
21.4.8. Becton Dickenson & Company
21.4.8.1. Overview
21.4.8.2. Product Portfolio
21.4.8.3. Key Financials
21.4.8.4. Sales Footprint
21.4.8.5. SWOT Analysis
21.4.8.6. Strategy Overview
21.4.8.6.1. Marketing Strategy
21.4.8.6.2. Product Strategy
21.4.8.6.3. Channel Strategy
21.4.9. Accelerate Diagnostics, Inc.
21.4.9.1. Overview
21.4.9.2. Product Portfolio
21.4.9.3. Key Financials
21.4.9.4. Sales Footprint
21.4.9.5. SWOT Analysis
21.4.9.6. Strategy Overview
21.4.9.6.1. Marketing Strategy
21.4.9.6.2. Product Strategy
21.4.9.6.3. Channel Strategy
21.4.10. Bruker
21.4.10.1. Overview
21.4.10.2. Product Portfolio
21.4.10.3. Key Financials
21.4.10.4. Sales Footprint
21.4.10.5. SWOT Analysis
21.4.10.6. Strategy Overview
21.4.10.6.1. Marketing Strategy
21.4.10.6.2. Product Strategy
21.4.10.6.3. Channel Strategy
21.4.11. EUCAST
21.4.11.1. Overview
21.4.11.2. Product Portfolio
21.4.11.3. Key Financials
21.4.11.4. Sales Footprint
21.4.11.5. SWOT Analysis
21.4.11.6. Strategy Overview
21.4.11.6.1. Marketing Strategy
21.4.11.6.2. Product Strategy
21.4.11.6.3. Channel Strategy
21.4.12. Generon S.p.A.
21.4.12.1. Overview
21.4.12.2. Product Portfolio
21.4.12.3. Key Financials
21.4.12.4. Sales Footprint
21.4.12.5. SWOT Analysis
21.4.12.6. Strategy Overview
21.4.12.6.1. Marketing Strategy
21.4.12.6.2. Product Strategy
21.4.12.6.3. Channel Strategy
21.4.13. Bio-Rad Laboratories
21.4.13.1. Overview
21.4.13.2. Product Portfolio
21.4.13.3. Key Financials
21.4.13.4. Sales Footprint
21.4.13.5. SWOT Analysis
21.4.13.6. Strategy Overview
21.4.13.6.1. Marketing Strategy
21.4.13.6.2. Product Strategy
21.4.13.6.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Explore Healthcare Insights
View Reports
Polymyxin Resistance Testing Market
